French private equity firm Keensight Capital announced it has agreed to acquire a majority stake in Isto Biologics from Thompson Street Capital Partners. Founded in 2016, Isto Biologics is a regenerative MedTech company developing and manufacturing orthobiologic products to help patients heal faster. Isto’s product offering covers six functional areas of […]
The post Keensight Capital Acquires Majority Stake in Isto Biologics appeared first on LevinPro Healthcare M&A – The latest healthcare M&A news.
